Abstract: A depressant of capsaicin-sensitive sensory nerve, containing quinuclidin-3?-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a salt thereof as an active ingredient, specifically a therapeutic drug of interstitial cystitis, hypersensitive disorder of the lower urinary tract, and/or abacterial prostatitis.

Abstract: Milk production and feed efficiency are improved by feeding the animal producing the milk a diet of feed comprising a substituted 1,2-dihydroquinoline compound.

Abstract: Compounds of formula (I) as defined herein: are useful for treating behavioral disorders associated with dementia, psychoses, in particular schizophrenia (deficient form and productive form) and acute or chronic extrapyramidal symptoms induced by neuroleptics; for the treatment of various forms of anxiety, panic attacks, phobias, and compulsive obsessive disorders; for treating various forms of depression, including psychotic depression; for treating disorders caused by alcohol abuse or weaning from alcohol, sexual behavior disorders, eating disorders and for treating migraine.

Abstract: Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals The invention relates to arylcycloalkyl-substituted alkanoic acid derivatives and to their physiologically acceptable salts and physiologically functional derivatives. What is described are compounds of the formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable, for example, for the treatment and/or prevention of disorders of the fatty acid metabolism and glucose utilization disorders and also disorders in which insulin resistance is involved.

Abstract: Substituted pyridines and pyrimidines and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duoden

Abstract: A 2,3-diphenylpropionic acid derivatives or the salts represented by general formula (1) below; and pharmaceutical compositions and cell adhesion inhibitors comprising the derivatives or the salts as the active ingredient.

Abstract: A targetted production method for benzothiazole-4,7-dione and benzoxazole-4,7-dione derivatives, mono-substituted in the 5 or 6 position with an amino group, itself optionally substituted.

Abstract: The present invention provides an aqueous suspension formulation containing (RS)-N-[2-(1,3-dimethylbutyl)thiophene-3-yl]-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide and having high rain resistance and stable residual effectiveness. A aqueous suspension formulation for foliar application fungicide of the present invention contains a fungicidal active ingredient, (RS)-N-[2-(1,3-dimethylbutyl)thiophene-3-yl]-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide, and a polyoxyalkylene rosin acid ester or liquid paraffin, and has improved rain resistance on plant leaves and excellent residual effectiveness.

Abstract: This invention generally relates to methods for treating or preventing an inflammatory disease or disorder comprising administering to a patient in need thereof an effective amount of a Pyrazoloanthrone Derivative having the following structure: or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are as defined herein.

Abstract: Novel compounds that are inhibitors of one or most post-proline cleaving proteases, e.g. dipeptidyl peptidase IV, according to general formula (1). R1 is H or CN, X1 is O, S, CH2, CHF, CF2, CH(CH3), C(CH3)2 or CH(CN), and b is 1 or 2. G1 is H or a group according to the formula —CH2—X2—(CH2)a-G3 and G2 is H or a group according to the formula —CH2—(CH29a-G3, provided that one of G1 and G2 is H and the other is not H. X2 is O, S, or CH2, and a is 0, 1 or 2, provided that when a is 1 then X2 is CH2. G3 is a group according to one of general formulae 2-4, where the variables have meaning given in the description. The compounds are useful in the treatment of i.a.

Abstract: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity, wherein X1, X2, X3, X4, X5, R5, R6, R7, R8a, R8b, R9, Z1, Z2, and L are defined in the description.

Abstract: Novel Wortmannin analogs and their use in inhibiting inhibiting PI-3-kinase activity in mammals as well as tumor formation in a subject are described herein.

Abstract: Substituted pyrrolidine compounds are provided, and methods of treatment and pharmaceutical composition that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing preterm labor, dysmenorrhea, asthma, hypertension, infertility or fertility disorder, undesired blood clotting, preeclampsia or eclampsia, an eosinophil disorder, sexual dysfunction, osteporosis and other destructive bone disease or disorder, and other diseases and disorders associated with the prostaglandin family of compounds. In a preferred aspect, a substituted pyrrolidine compound is administered to a subject in coordination with a phosphodiesterase inhibitor compound.

Abstract: Novel prodrugs of amino ceramide-like compounds are provided which inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase, thereby lowering the level of glycosphingolipids. The compounds of the present invention have improved GlcCer synthase inhibition activity and are therefore highly useful in therapeutic methods for treating various conditions and diseases associated with altered glycosphingolipid levels.

Abstract: A pharmaceutical composition for the treatment of immune-related diseases of ocular surface and the anterior segment of the eye. More specifically, the invention relates to a composition comprising tacrolimus in a pharmaceutically acceptable formulation, particularly a suitable local treatment formulation, such as eye drops and ointments. Also disclosed is a method for the treatment of immune-response related ocular diseases of the anterior segment of the eye and the eye surface, wherein the method comprises administering to a patient in need thereof the pharmaceutical composition of the present invention. The method of the present invention preferably further comprises administering to the patient an immunosuppressant in addition to tacrolimus.

Abstract: Compositions and methods for therapy of cystic fibrosis and other conditions are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis and/or another condition responsive to stimulation of chloride transport.

Abstract: The present invention relates to compounds being esters of 5-aminolevulinic acids or pharmaceutically acceptable salts thereof, including compounds of formula (I) R22N—CH2COCH2-CH2CO—OR1 (wherein R1 may represent alkyl optionally substituted by hydroxy, alkoxy, acyloxy, alkoxycarbonyloxy, amino, aryl, oxo or fluoro groups and optionally interrupted by oxygen, nitrogen, sulphur or phosphorus atoms; and R2 represents a hydrogen atom or a group R1, and both R2 groups may be the identical or different), and their use in diagnosis and photochemotherapy of disorders or abnormalities of external or internal surfaces of the body, and products and kits for performing the invention.

Abstract: Disclosed is crystalline ladostigil tartrate of a specified density, compositions, including pharmaceutical compositions comprising such ladostigil tartrate, and a process for the manufacture thereof.

Abstract: This invention relates to a novel class of acidic amino acid/dicarboxylic acid derivatives (sulfonic acid/sulfate derivatives of naturally occurring amino acids and their amides) useful as inhibitors of osteoclastogenesis. The invention also provides methods of using the novel class of acidic amino acid/dicarboxylic acid derivatives of the general formula ZOC—(CRR)m—COOH, wherein: m=2, 3 or 4; Z is OH or NH2; one R in the compound is from the group consisting of SO3H, OSO3H, CH2—SO3H, CH2—OSO3H, and NHSO3H, and the remaining Rs are H or NH2, for inhibition of osteoclastogenesis.

Abstract: The present invention relates to aminocyclohexanol derivatives useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.

Abstract: Novel polycyclic cannabinoid analogs are presented which have preferentially high affinities for the cannabinoid CB2 receptor sites. The improved receptor affinity makes these analogs therapeutically useful as medications in individuals and animals for treatment of pain, glaucoma, epilepsy, nausea associated with chemotherapy.

Abstract: The present invention relates to novel dihydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient.

Abstract: The present invention provides crosslinkable compositions useful in the preparation of hydrophilic gels, and are prepared from polymers having pendent hydrophilic groups, and pendant Michael donor groups, and crosslinked by polyacryl Michael acceptor compounds.

Abstract: Disclosed are dental varnishes comprising reaction products of rosins with polyalcohols dissolved in mixtures of C2-C4 alcohols with C5-C7 hydrocarbons which have been found effective in preventing tooth decay and alleviating tooth sensitivity. Such varnishes may, optionally, incorporate therapeutic, antimicrobial and sensory enhancing ingredients.

Abstract: The present invention relates to a cross-linkable or cross-linked rubber composition usable in a tread of a tire, and to a tire incorporating this tread. A rubber composition according to the invention is based on at least one diene elastomer, and a plasticizer comprising a glycerol oleic acid triester, said plasticizer comprises: one or more synthetic and/or natural compounds not extracted from petroleum in a mass fraction of from 45% to 100%, said compounds comprising at least one glycerol fatty acid triester, and the fatty acid(s) as a whole comprise oleic acid in a mass fraction equal to or greater than 60%, and one or more paraffinic, aromatic or naphthenic type plasticizing oils extracted from petroleum in a mass fraction of from 55% to 0%. The invention applies in particular to tires of passenger-vehicle type.

Abstract: The invention relates to an antioxidant for polyamides containing a sterically hindered phenol of formula (I) as a single primary antioxidant, wherein n is a mixture of whole numbers from 1-5. The invention also relates to compositions containing a polyamide and a compound of formula (I) as a single primary antioxidant.

Abstract: Disclosed is a polypropylene resin composition comprising (A) 100 parts by weight of polypropylene resin and the following components (B) to (D): (B) from 0.001 to 0.1 part by weight of an inorganic neutralizing agent, (C) from 0.01 to 5 parts by weight of an antioxidant, and (D) from 0.01 to 0.5 part by weight of particles of sodium benzoate having an average particle diameter, as measured by a laser method, of from 0.1 to 3.75 ?m wherein particles having particle diameters of not less than 10 ?m account for less than 15% by weight.

Abstract: A laminar pigment which has hydrolyzed silane coupling agent treated surface is used as a pigment for a powder coating composition. By combining the pigment with a powdery film-forming polymer, a film-forming composition, which can be applied by electrostatic coating is produced. With the addition of leveling agent to the silane treated products, the spray properties of effect pigments are improved. The products of this invention are useful in all types of automotive and industrial paint applications.

Abstract: This invention pertains to highly filled polymer compositions comprising a low molecular weight ethylene and/or alpha olefin homopolymers and copolymers, or blends therefrom, filled with high concentrations of fillers or additives. Examples of such fillers or additives include fire retardants, talc, ceramic manufacturing agents, color concentrates, crosslinking agents, and blowing agents. Because of the low crystallinity (and therefore high percentage of amorphous phase) and low viscosities of the base polymers, highly processable compositions can be formed containing even if containing relatively high loadings of fillers or additives. Such highly filled compositions are thus ideally suited as concentrates or masterbatch formulations for a variety of different compounding applications.

Abstract: The invention provides a polymer composition comprising cross-linked polyethylene having a non-polar biocompatible lipid disposed in at least a portion of the free volume of the polyethylene. The invention further provides methods for making the polymer composition.

Abstract: An ethylenically unsaturated group-containing fluoropolymer, which is obtained by reacting a compound containing one isocyanate group and at least one ethylenically unsaturated group, and a hydroxyl group-containing fluoropolymer at an isocyanate group/hydroxyl group molar ratio of 1.1 to 1.9. According to the present invention, an ethylenically unsaturated group-containing fluoropolymer having superior antiscratching property, coating property and durability, as well as a curable resin composition and an antireflection film using the same can be provided.

Abstract: A description is given of water-soluble aminoplast ether copolymers of the following structural type: wherein Z is a glycoluril central unit, B is a radical of an essentially water-insoluble polymer and R1 is a radical of a hydrophilic organic compound. The ratio R1:B is selected within a range of about 1.5 to 4:1 and the overall mass of the water-soluble aminoplast ether copolymer is from about 2000 to 50 000 g/mol such that the copolymer is soluble in water and may be used as a dispersant for e.g. pigments in polar solvents, e.g. water.

Abstract: The present invention relates to a block polymeric material. Typically the block polymer comprises units capable of having an average cationic charge density of about 15 or less, preferably 5 or less, more preferably from about 0.05 to about 5, even more preferably from about 0.05 to about 2.77, even more preferably from about 0.1 to about 2.75, most preferably from about 0.75 to about 2.25 units per 100 daltons molecular weight at a pH of from about 4 to about 12. The polymeric material is a suds enhancer and a suds volume extender for personal care products such as soaps and shampoos. The compositions have increased effectiveness for preventing re-deposition of grease during hand and body washing. The polymers are also effective as a soil release agent in fabric cleaning compositions.

Abstract: A magnetic disk is produced with improved yield by forming a DLC protective film by a d.c. magnetron sputtering process conducted in a sputtering atmosphere containing oxygen. The magnetic disk carries a lubricating film on the DLC film wherein a fluorocarbon resin constituting the lubricating film contains photocrosslinking groups. A lubricating film having non-polar end groups is also disclosed.

Abstract: A photochromic plastic object made of a transparent synthetic resin material composed of at least two mutually penetrating polymer networks of different polymer materials and containing at least one photochromic dye homogeneously distributed therein, and a method for producing such a photochromic object.

Abstract: A novel polyolefin graft copolymer prepared by graft-copolymerizing an olefin monomer with a (meth)acryl macromonomer or an isobutylene macromonomer in the presence of a coordination polymerization catalyst based on a late transition metal complex and a method for making the novel polyolefin graft copolymer are provided.

Abstract: The present invention relates to novel functional norbornenes as initiators for radical polymerization, its polymer and a process for producing the same. More particularly, the novel functional norbornenes can be selectively polymerized by ring-opening metathesis polymerization or radical polymerization to obtain various polynorbornene derivatives or grafted copolymer materials. The polynorbornene derivatives and grafted copolymer materials not only exhibit excellent functional properties but also enhanced physical and chemical properties after modification. The polynorbornene derivatives and grafted copolymer materials disclosed in the present invention exhibit excellent heat resistance, transparency and water resistance. The present invention also deals with a process for producing such derivatives and materials having controllable molecular weight with narrow molecular weight distribution.

Abstract: Fluoropolymers are disclosed. The fluoropolymers include (i) units derived from a fluoromonomer composition comprising chlorotrifluoroethylene, and (ii) units derived from at least one donor monomer composition. In the disclosed fluoropolymers, units (i) and (ii) are distributed along the fluoropolymer chain in a substantially alternating fashion. Also disclosed are thermosetting compositions containing such fluoropolymers, substrates coated with such compositions, methods for making such compositions, and methods for coating substrates with such compositions.

Abstract: The present invention is directed to a method for synthesizing rubbery copolymers, such as styrene-butadiene rubber, or rubbery homopolymers, such as polybutadiene rubber, that are alkoxy functionalized, e.g., alkoxysilane functionalized, and provide desirable dispersion of silica in rubber compounds, such as for use in tire treads. To that end, the method, in one embodiment, involves admixing anionically polymerizable conjugated diene monomers with optional vinyl aromatic, an anionic-polymerization initiator, i.e., an organolithium compound, and a lithium alkoxide to form an admixture of living polymers, then adding a halogenated coupling agent to the admixture of living polymers effecting conditions to form an alkoxy functionalized rubbery polymer. The alkoxy functionalized rubbery polymers can be utilized in tire tread rubbers where the rubbery polymers may provide desirable wear properties without substantially sacrificing other performance characteristic(s), e.g., traction properties.

Abstract: A barrier layer composition for a pneumatic tire that contains a mixture of an 4-phenyl isocyanate and sulfur as a crosslinking material, with higher than normal levels of filler or reinforcing material loading. The barrier layer formulation exhibited improved green strength properties, and also improved aged flex life, aged tear, and reversion resistance.

Abstract: The present invention relates to an addition-cross-linking two component silicone material containing one or more organopolysiloxanes having at least two vinyl groups in the molecule, at least one cross-linking agent and at least one catalyst, wherein the material contains more than 1 wt %, relative to the total quantity of the two-component silicone material, of at least one organopolysiloxane of general formula I CH2?CH—SiR1R2O—(SiR1R2O)n—SiR1R2—CH?CH2, in which R1 and R2 are identical or different and are selected from the group comprising alkyl groups, aryl groups, aralkyl groups, halogen-substituted alkyl groups, halogen-substituted aralkyl groups, cyanoalkyl groups, cycloalkyl groups and cycloalkenyl groups, and n is an integral number between 1 and 9, as well as to the use of this silicone material.

Abstract: The invention relates to water-soluble, preferably powder-form polymer compositions which are obtained by continuous polymerization of at least one unsaturated monomer. At least one parameter that influences the polymerization is varied according to a recurrent pattern. The invention also relates to the use of the inventive polymer compositions and to a method for producing them.

Abstract: A process for the polymerisation of olefins is described involving the use of a catalyst system comprising a supported transition metal compound and an activator based on an organoborane and an aluminoxane. Preferably the transition metal compound is a metallocene complex. The support is pretreated with an organoaluminium compound and the process is particularly suitable for the gas phase preparation of copolymers of ethylene and alpha-olefins having a molecular weight distribution in the range 2.5-7.0 and a melt strength in the range 3-12 cN.

Abstract: Catalyst compositions and processes for the polymerization of ethylenically unsaturated monomers to produce polymers, including copolymers or homopolymers. Such monomers include ethylene, C3+ alpha olefins and substituted vinyl compounds, such as styrene and vinyl chloride. The polymerization catalyst characterized by the formula B(FluL)MQn in which Flu is a fluorenyl group substituted at at least the 2,7- and 3,6-positions by hydrocarbyl groups, preferably relatively bulky hydrocarbyl groups.

Abstract: This invention relates to siloxy-functionalized polymers having the silicon of the siloxy group directly bonded to the end of a polymer chain through one or more carbon atoms, processes of producing the polymers, and initiators used to prepare the polymers. The polymers may be rubbery polymers, such as butadiene-styrene polymers, which are commonly used in tires.

Abstract: A process of making the flexible superabsorbent binder polymer composition includes preparing a preneutralized monomer solution having at least about 40 mol % degree of neutralization, preparing a monomer solution including monoethylenically unsaturated monomers, one of which includes an alkyloxysilane functionality, preparing initiator system solutions and adding the solutions to the monomer solution, mixing the foregoing solutions into a polymerization solution, cooling the polymerization solution, and post neutralizing the polymer.

Abstract: The present invention is directed to sulfine control agents for synthesizing polymers via controlled free radical polymerization and to the polymers resulting therefrom. Such polymers include repeat units derived from the controlled free radical polymerization, particularly reversible atom fragmentation transfer (RAFT) polymerization, of at least one vinyl-containing monomer, at least one conjugated diene monomer, or combinations thereof, in the presence of a sulfine compound having the formula: wherein R1 is alkyl, cycloalkyl, substituted alkyl, heteroalkyl, heterocycloalkyl or substituted heterocycloalkyl, and wherein Y is alkyl, cycloalkyl, substituted alkyl, heteroalkyl, heterocycloalkyl, substituted heterocycloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkoxy, amino or thio.

Abstract: An ethylene-?-olefin copolymer having monomer units derived from ethylene and monomer units derived from an ?-olefin of 3 to 20 carbon atoms, a density of 906 to 970 kg/m3, an activation energy of flow of 50 kJ/mol or more and a heat quantity of fusion of a cold xylene soluble part of 30 J/g or more, and satisfying specific relations among a rate of the cold xylene soluble part in the copolymer, the density, a melt flow rate and a characteristic relaxation time.

Abstract: An ethylene (co)polymer of the present invention is a (co)polymer with excellent moldability and mechanical properties and either an ethylene homopolymer or a copolymer of ethylene and an ?-olefin of 4 to 20 carbon atoms. The (co)polymer has methyl branches measured by 13C-NMR less than 0.1 in number per 1,000 carbon atoms and Mw/Mn measured by GPC not lower than 1.8 and lower than 4.5. The (co)polymer is either an ethylene homopolymer or a copolymer of ethylene and an ?-olefin of 3 to 20 carbon atoms. The melt tension (MT) and the swell ratio (SR) satisfy the relation; log(MT)>12.9?7.15×SR; and the intrinsic viscosity ([?]) and the melt flow rate (MFR) satisfy the relation; [?]>1.85×MFR?0.192 in the case of MFR?1 and the relation; [?]>1.85×MFR?0.213 in the case of MFR?1. Such an ethylene (co)polymer can be usable for various molding applications and especially suitable for pipes.

Abstract: The in vitro polymerization of silica, silicone, non-silicon metalloid-oxane and metallo-oxane polymer networks, by combining a catalyst and a substrate to polymerize the substrate to form silica, polysiloxanes, polymetalloid-oxanes polymetallo-oxanes (metal oxides), polyorganometalloid oxanes, polyorganometallo oxanes, and the polyhydrido derivatives thereof, at about neutral pH.